Replies to post #1399 on Repros Therapeutics Inc (RPRX)

[docbanker]

Yes, the Company raising money and doing so in a "surprise" fashion, i.e. doing a PIPE or something couldn't be further from the M.O. of the company to date. They signalled the market they were going to raise money in Q1 of 2007 since mid-2006. Some would argue doing so was to their detriment as the stock only rose from $6 to $13 on 3 trials worth of solid interim results.
I believe either the company will partner Androxal or perhaps a secondary indication of a Proellex-like compound (for something like breast CA) or something else in lieu of raising money. Should one of these partnerships be delayed and they have to raise money, I don't see how that is necessary until conservatively Q3 '08 (they could wait longer), so why worry about what small financing may or may not take place in 12+ months?

[zipjet]

>> They have enough cash for this year and part of next.

Some would say that is far too little cash for a cash-burn biotech.

One of my little bios filed a shelf to raise cash and they have OVER 4 years at the projected burn rate.

>>and this isn't the best time in the market to be trying to raise,

The lower your time to burn cash - the worse your position. With only a year of cash, how can you wait - 9 months from now could be MUCH worse.

zip